EXPORT CITATION

Chapter-175 A Prospective, Randomized, Double-blind, Comparative Clinical Study of Efficacy and Safety of a Biosimilar Adalimumab with Innovator Product in Patients with Active Rheumatoid Arthritis on a Stable Dose of Methotrexate

BOOK TITLE: Year Book of Medicine 2019

Author
1. Handa Rohini
2. Sharma Aman
3. Misra Durga Prasanna
ISBN
9789389188738
DOI
10.5005/jp/books/18366_177
Edition
1/e
Publishing Year
2019
Pages
2
Author Affiliations
1. Apollo Indraprastha Hospital, New Delhi, India, All India Institute of Medical Sciences, New Delhi, Apollo Indraprastha Hospitals, New Delhi, India, Indraprastha Apollo Hospitals, New Delhi, India
2. Postgraduate Institute of Medical Education and Research, Chandigarh, India, Apollo Hospital, Bilaspur, Chhattisgarh, India, PGIMER, Chandigarh, India, New Cross Hospital, Wolverhampton, United Kingdom, Post Graduate Institute of Medical Education and Research, Chandigarh, India, Postgraduate Institute of Medical, Education and Research (PGIMER), Chandigarh, India
3. Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, SGPGI, Lucknow, Uttar Pradesh, India
Chapter keywords
Biosimilar adalimumab, active rheumatoid arthritis, methotrexate, health assessment questionnaire-disability index, HAQ-DI, rheumatoid factor, RF, disease activity score 28 joint, DAS28, C-reactive protein, CRP, adverse event, AE

Abstract

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved